Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Additionally, APB, assessed, attributable, component, condensed, deal, decided, efficacy, EITF, footnote, fourth, fully, legal, maintenance, modest, pace, patient, plasma, portfolio, prepaid, protocol, prototype, ranging, safety, segment, showed, similar, structure, suppression, type, unexpected, verification
Removed:
abstract, accrued, acute, alpha, alternate, alternative, amendment, anticipating, assumed, beneficial, blood, breakthrough, burn, cancellation, conducted, contractual, credit, design, dividend, entered, equal, exercisable, exploitation, gene, geneRx, GlaxoSmithKline, Group, hold, injection, intellectual, interferon, Interpretation, invested, Involving, issuance, June, leading, licensing, narcotic, opioid, pain, participate, partnered, plc, potentially, predict, prior, reflecting, regulating, repriced, responsibility, restoration, restore, sell, session, small, stage, Standard, test, therapy, UK, unused, volatility, warrant, yield
Filing tables
Filing exhibits
ARDMQ similar filings
Filing view
External links